Sienna Biopharmaceuticals, Inc.
SNNAQ
$0.00
$0.000.00%
OTC PK
| 09/30/2019 | 06/30/2019 | 03/31/2019 | 12/31/2018 | 09/30/2018 | |
|---|---|---|---|---|---|
| Net Income | -- | 6.39% | -26.43% | -45.36% | -37.11% |
| Total Depreciation and Amortization | -- | 6.90% | 18.05% | 30.83% | 52.43% |
| Total Amortization of Deferred Charges | -- | -- | -23.48% | -64.47% | -82.17% |
| Total Other Non-Cash Items | -- | 205.23% | 129.87% | 14.44% | -89.10% |
| Change in Net Operating Assets | -- | -195.26% | -181.61% | 108.09% | -25.30% |
| Cash from Operations | -- | 1.89% | -21.32% | -50.43% | -88.70% |
| Capital Expenditure | -- | 88.02% | 82.89% | 85.77% | 47.10% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -100.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 88.02% | 82.27% | 85.34% | 98.06% |
| Total Debt Issued | -- | -100.10% | -- | 664.62% | 664.29% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -59.51% | -58.63% | -90.85% | -91.25% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -72.01% | -44.19% | -66.32% | -66.61% |
| Foreign Exchange rate Adjustments | -- | -489.19% | -362.34% | -225.00% | 125.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -159.49% | -105.34% | -139.64% | -136.32% |